Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock
NCT ID: NCT05833607
Last Updated: 2023-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2022-07-07
2024-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients participating in the study will be submitted to different levels of arterial pressure, titrated with vasopressor and them their cerebral hemodynamic variables will be evaluated,
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
NCT02519699
Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock
NCT04398069
Hemodynamic Effects of Vasopressin in Early Septic Shock Stage
NCT02053675
Cerebral Pulsatility Index Compared To Mean Arterial Blood Pressure Guided Protocol In Sepsis Induced Encephalopathy:
NCT05842616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The principle of cerebral autoregulation (CA) is the basic defense mechanism against pressure oscillations in the most diverse contexts. The SC is a state of vasodilation and consequent drop in mean arterial pressure (MAP), that under normal physiological conditions would be compensated by CA. But it is not known exactly how CA performance at this profile of patients.
The investigators will assess cerebral hemodynamics in SC patients at different MAP targets, in order to identify whether this regulatory variable would be able to generate better parameters of cerebral hemodynamics.
Some smaller studies have shown that liver and heart dysfunction correlate with worsening autoregulation. Another clinical trial showed an inverse relationship between CA and the Sequential Organ Failure Assessment, in addition to the loss of CA in patients with circulatory shock in general. Post-mortem data found generalized ischemic lesions in the brain of septic patients, which translates into a state of reduction at vascular flow. This patient profile has more blood-brain barrier dysfunction, but further studies are needed to correlate CA and CS.
The study will be carried out in the ICU of Hospital São Rafael (HSR), located in the city of Salvador-Ba, Brazil. For the evaluation of cerebral hemodynamics Transcranial Doppler and a Mechanical sensor (B4C) will be used.
Data collection on admission will include the following: demographic characteristics, comorbidities, source of infection, Sequential Organ Failure Assessment (SOFA) at ICU admission, temperature, Glasgow Coma scale (GCE) or Richmond Agitation Sedation Scale (RASS), mechanical ventilation, arterial blood gasses before and after the protocol.
All patients will be monitored with an arterial line, cardioscopy, pulse oximetry and capnography (if unavailable at the time of collection, this will be described). Before starting the monitoring, the proper functioning of the arterial circuit will be confirmed and a blood gas analysis will be collected, as well as at the end.
The investigators will collet data with the patient's baseline pressure for 5 minutes (T0), then through the titration of vasopressors, for another 5 minutes each mean arterial pressure target at 65mmHg (T1), 75 mmHg (T2) and 85 mmHg (T3). After collection, the baseline mean arterial pressure will be restored
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ALL PATIENTS
All patients are monitored with the transcranial Doppler helmet and the 2Hz probe in one of the middle cerebral hemispheres and the Brain 4 care on the other side.
Necessary monitoring: arterial line, electrocardiographic monitor, pulse oximetry, temperature. ETCO2 monitoring whenever possible.
Step 1: Test arterial line circuit, ensure proper temperature, arterial blood gases Step 2: Record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), for 5 min Step 3: Vasopressor titrant for 3 MAP targets (65, 75 and 85 mmHg) , record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), each target record for 3 minutes Step 4: Arterial blood gases, gradually restore PAM to baseline value
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Septic shock (sepsis 3.0)
Exclusion Criteria
* Hepatic or uremic encephalopathy
* Pregnancy
* Acute or prior structural neurological insult
* Exogenous intoxication
* Dementia
* Chronic Obstructive Pulmonary Disease
* Instability for acute arrhythmia
* Extracorporeal support by modifying the pulse wave form (intra aortic balloon pump and Extracorporeal membrane oxygenation
* Extreme severity, with imminent risk of death
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
D'Or Institute for Research and Education
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juliana Caldas, Phd
Role: PRINCIPAL_INVESTIGATOR
D'Or Institute for Research and Education (IDOR), Hospital São Rafael
Pedro Cury
Role: STUDY_CHAIR
D'Or Institute for Research and Education (IDOR), Hospital São Rafael
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
São Rafael Hospital
Salvador, Estado de Bahia, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cury P, Passos RDH, Alves F, Brasil S, Frigieri G, Taccone FS, Panerai RB, Caldas J. Impact of different blood pressure targets on cerebral hemodynamics in septic shock: A prospective pilot study protocol-SEPSIS-BRAIN. PLoS One. 2024 Oct 14;19(10):e0304412. doi: 10.1371/journal.pone.0304412. eCollection 2024.
Related Links
Access external resources that provide additional context or updates about the study.
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Cerebral dysfunctions caused by sepsis during ageing
Cerebral autoregulation
Dynamic Autoregulation is Impaired in Circulatory Shock
Impaired cerebral autoregulation is associated with brain dysfunction in patients with sepsis
Waveform Morphology as a Surrogate for ICP Monitoring: A Comparison Between an Invasive and a Noninvasive Method
Noninvasive intracranial pressure waveforms for estimation of intracranial hypertension and outcome prediction in acute brain-injured patients
Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors
POCUS, how can we include the brain? An overview
A Novel Noninvasive Technique for Intracranial Pressure Waveform Monitoring in Critical Care
Daily blood pressure variability in relation to neurological functional outcomes after acute ischemic stroke
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
28134720.1.0000.0048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.